Insider Trading & Ownership - Cohen Joshua B

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cohen Joshua B
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-30
Sale
2024-10-02
6:53 pm
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
18,589$3.1962$59,4143,220,569
(Direct)
View
2024-03-05
Sale
2024-03-07
4:05 pm
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
4,135$18.73$77,4403,023,002
(Direct)
View
2024-01-09
Sale
2024-01-11
5:10 pm
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
5,841$16.33$95,3722,900,470
(Direct)
View
2023-03-16
Sale
2023-03-20
8:21 pm
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
100,000$31.86$3,186,3363,067,617
(Direct)
View
2023-01-06
Sale
2023-01-10
7:20 pm
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
5,968$36.3$216,6292,892,617
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-23
Exercise
2024-09-25
5:56 pm
N/A
2025-02-26
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
1,857$03,239,158
(Direct)
View
2024-09-23
Exercise
2024-09-25
5:56 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
1,857$1.573,239,158
(Direct)
View
2024-09-12
Exercise
2024-09-16
5:39 pm
N/A
2025-02-26
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
34,449$03,239,158
(Direct)
View
2024-09-12
Exercise
2024-09-16
5:39 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
34,449$1.573,239,158
(Direct)
View
2024-04-16
Option Award
2024-04-18
8:21 pm
N/A
2034-04-15
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
559,850$03,582,852
(Direct)
View
2024-02-26
Option Award
2024-02-28
6:22 pm
N/A
2034-02-25
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
316,667$03,217,137
(Direct)
View
2023-11-16
Exercise
2023-11-20
8:20 pm
N/A
2025-02-26
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
63,694$02,942,617
(Direct)
View
2023-11-16
Exercise
2023-11-20
8:20 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
63,694$1.572,942,617
(Direct)
View
2023-03-16
Option Award
2023-03-20
8:21 pm
N/A
2033-03-16
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
275,000$03,067,617
(Direct)
View
2022-05-05
Exercise
2022-05-06
4:05 pm
N/A
2023-02-16
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
334,520$02,898,585
(Direct)
View
2022-05-05
Exercise
2022-05-06
4:05 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
334,520$0.372,898,585
(Direct)
View
2022-01-06
Conversion
2022-01-10
8:32 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
4,870$02,901,565
(Direct)
View
2022-01-06
Option Award
2022-01-10
8:32 pm
N/A
2032-01-06
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
412,500$02,901,565
(Direct)
View

Ownership
2022-01-06
5:10 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXCohen Joshua B
Co-Chief Executive Officer
0$03,123,585
(Direct)
View